Literature DB >> 8887997

Effects of chronic haloperidol on stress- and stimulation-induced increases in dopamine release: tests of the depolarization block hypothesis.

M A Klitenick1, M T Taber, H C Fibiger.   

Abstract

There is considerable neurophysiological evidence that chronically administered neuroleptics can, under certain circumstances, decrease the activity of mesencephalic dopaminergic neurons. This finding, referred to as depolarization inactivation or depolarization block, has led to the hypothesis that the delayed therapeutic effects of neuroleptic drugs are due to a graduate silencing of mesolimbic dopaminergic neurons. One prediction of depolarization inactivation is that dopamine neurons in this state should be resistant to activation by excitatory stimuli. As a test of this prediction, rats that had been treated chronically with either saline or haloperidol (0.5 mg/kg x 21 days) were exposed to either acute mild stress or electrical stimulation of the prelimbic region of the prefrontal cortex while extracellular levels of dopamine in the nucleus accumbens were monitored by in vivo microdialysis. A 10-minute exposure to acute stress via tail pinch increased dopamine release by 20% and 18% in the saline and haloperidol groups, respectively. Similarly, 20 minutes of cortical stimulation increased dopamine release by 51% and 56% in rats treated chronically with saline or haloperidol, respectively. These results indicate that contrary to a prediction of the depolarization block hypothesis, mesolimbic dopaminergic neurons can be activated in neuroleptic-treated animals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887997     DOI: 10.1016/0893-133X(96)00017-6

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  9 in total

Review 1.  Brain temperature and its role in physiology and pathophysiology: Lessons from 20 years of thermorecording.

Authors:  Eugene A Kiyatkin
Journal:  Temperature (Austin)       Date:  2019-12-03

2.  Aversive stimulus differentially triggers subsecond dopamine release in reward regions.

Authors:  E A Budygin; J Park; C E Bass; V P Grinevich; K D Bonin; R M Wightman
Journal:  Neuroscience       Date:  2011-11-07       Impact factor: 3.590

3.  Combining the Antipsychotic Drug Haloperidol and Environmental Enrichment after Traumatic Brain Injury Is a Double-Edged Sword.

Authors:  Kaitlin A Folweiler; Corina O Bondi; Elizabeth A Ogunsanya; Megan J LaPorte; Jacob B Leary; Hannah L Radabaugh; Christina M Monaco; Anthony E Kline
Journal:  J Neurotrauma       Date:  2016-04-20       Impact factor: 5.269

Review 4.  Brain Circuits Encoding Reward from Pain Relief.

Authors:  Edita Navratilova; Christopher W Atcherley; Frank Porreca
Journal:  Trends Neurosci       Date:  2015-11       Impact factor: 13.837

Review 5.  Ventral tegmental area dopamine revisited: effects of acute and repeated stress.

Authors:  Elizabeth N Holly; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2015-12-17       Impact factor: 4.530

6.  Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurons.

Authors:  H Moore; C L Todd; A A Grace
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

7.  Relationship of Dopamine of the Nucleus Accumbens with Intra-infralimbic Apomorphine Microinjection.

Authors:  Abbas Alimoradian; Javad Sajedianfard; Faegheh Baha-Aldini Beigy; Mohammad Reza Panjehshahin; Ali Akbar Owji
Journal:  Iran J Basic Med Sci       Date:  2013-06       Impact factor: 2.699

8.  Involvement of supralemniscal nucleus (B9) 5-HT neuronal system in nociceptive processing: a fiber photometry study.

Authors:  Shunpei Moriya; Akira Yamashita; Daiki Masukawa; Yuki Kambe; Junichi Sakaguchi; Honami Setoyama; Akihiro Yamanaka; Tomoyuki Kuwaki
Journal:  Mol Brain       Date:  2020-01-31       Impact factor: 4.041

Review 9.  Access to the CNS: Biomarker Strategies for Dopaminergic Treatments.

Authors:  Willem Johan van den Brink; Semra Palic; Isabelle Köhler; Elizabeth Cunera Maria de Lange
Journal:  Pharm Res       Date:  2018-02-15       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.